OBIO(OBIO)
OBIO
ANALYST COVERAGE5 analysts
BUY
▲ +225.0%upside to target
Key MetricsTTM
Market Cap$245.22M
Revenue TTM$32.72M
Net Income TTM-$54.64M
Free Cash Flow-$55.08M
Gross Margin—
Operating Margin—
Net Margin—
Return on Equity-138.0%
Return on Assets—
Debt / Equity0.03
Current Ratio7.03
EPS TTM$-1.42
PRICE
Prev Close
3.98
Open
3.94
Day Range3.94 – 4.04
3.94
4.04
52W Range2.20 – 5.42
2.20
5.42
56% of range
VOLUME & SIZE
Avg Volume
214.0K
FUNDAMENTALS
P/E Ratio
-4.2x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
TECHNICAL
RSI (14)
58
Bullish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 23
DEx-Dividend
In 90 days
Aug 20
PDividend Pay
In 119 days
Sep 18
OBIO News
About
No description available.
Sector
Industry
Surgical and Medical Instrument Manufacturing
William Reed LittleExecutive Vice President of Corporate Development & Strategy
Lisa DanielsVice President of Human Resources
Yuval Hay Mika D.ScGM & Chief Technology Officer of Bioelectronic Therapies
Andrew Lawrence TaylorChief Financial Officer
Bob LaughnerSenior Vice President of Regulatory & Quality
Avraham Matityahu FischerSenior Vice President of Medical Affairs & Innovation
Hans-Peter StollSenior Vice President & Medical Director
Darren R. ShermanFounder, President, Chief Operating Officer & Director
David HochmanFounder, Chairman of the Board of Directors & Chief Executive Officer
Juan LorenzoSenior Vice President of Product Development